lesquesne index

Known as: lequesne index 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
01219962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVES Chondroitin sulfate 800 mg/day (CS) pharmaceutical-grade in the management of symptomatic knee osteoarthritis… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2016
2016
OBJECTIVE To determine effects of Whole Body Vibration Exercise (WBVE) associated with quadriceps resistance exercises (QRE… (More)
  • figure 1
  • table 1
  • table 3
Is this relevant?
2016
2016
[Purpose] This study aimed to compare the efficacy of radiofrequency diathermy with that of microwave diathermy in combination… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
Until now glucosamine sulfate (GS) has been the most widely used supplement and has been shown to be efficacious in the treatment… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
OBJECTIVE Evaluation of the efficacy and safety of a single oral dose of a 1200 mg sachet of chondroitin 4&6 sulfate (CS 1200) vs… (More)
  • table I
  • figure 1
  • table II
  • table V
  • table III
Is this relevant?
2011
2011
BACKGROUND The clinical evidence of the efficacy of hyperthermia on osteoarthritis (OA) has not yet been clearly established. In… (More)
Is this relevant?
2011
2011
INTRODUCTION Osteoarthritis is a chronic rheumatoid disease mediated by metalloproteinases and inflammatory cytokines… (More)
Is this relevant?
2007
2007
The objective of this study was to test if spa therapy can play a role in the management of severe knee osteoarthritis (OA… (More)
Is this relevant?
2002
2002
The Lequesne Algofunctional Index is a widespread international instrument and recommended by the World Health Organization (WHO… (More)
Is this relevant?
2001
2001
OBJECTIVE To assess the efficacy and safety of chondroitin sulfate (CS) 1 g/day per os compared to placebo, in a double blind… (More)
Is this relevant?